You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GKA

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Shanghai (HMS5552, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Shanghai, China
    Hua Medicine Limited
Aug 24, 2021

Diabetes, Type 2 Trial in Shanghai (HMS5552, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Shanghai, Shanghai, China
    Hua Medicine Limited
Aug 24, 2021

Diabetes, Type 2 Trial in Nanjing (HMS5552, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing U
Feb 25, 2020

Chronic Kidney Disease Trial in Taichung (Placebo, Probiotics)

Not yet recruiting
  • Chronic Kidney Disease
  • Placebo
  • Probiotics
  • Taichung, ROC, Taiwan
    Taiwan
Apr 27, 2022

Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )

Completed
  • Diabetes Mellitus, Type 2
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Jul 19, 2022

Sarcopenia With SARC-F and Anthropometric Measurement

Completed
  • Sarcopenia
  • Older People
  • anthoropometric measurement, SARC- F questionnare
  • Izmir, Bornova, Turkey
    Ege University
Feb 18, 2022

The Progress of Diabetes Mellitus After HMS5552 Treatment in

Unknown status
  • Type2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First hospital
Aug 25, 2021

Type2 Diabetes Trial in Beijing (glucokinase activator, Placebo)

Completed
  • Type2 Diabetes Mellitus
  • glucokinase activator
  • Placebo
  • Beijing, China
    Peking University Third Hospital
Jan 21, 2020

Gestational Weight Gain Trial in Ordu (Activity of Whatsapp messages)

Recruiting
  • Gestational Weight Gain
  • Activity of Whatsapp messages
  • Ordu, Turkey
    Ordu University
Oct 20, 2022

Drug Interaction Trial in Shanghai (Dorzagliatin)

Completed
  • Drug Interaction
  • Shanghai, Shanghai, China
    Central Hospital of Xuhui District
Sep 4, 2019

Drug Interaction Trial in Changchun (Dorzagliatin)

Completed
  • Drug Interaction
  • Changchun, Jilin, China
    The 2nd Hospital of Jilin University
Sep 4, 2019

Type 2 Diabetes Trial in Hackensack (Metformin, HMS5552)

Completed
  • Type 2 Diabetes Mellitus
  • Hackensack, New Jersey
    Frontage Clinical Services Inc.
Feb 16, 2016